<DOC>
	<DOCNO>NCT02268773</DOCNO>
	<brief_summary>To compare combination acetylsalicylic acid ( 25 mg ) + modified-release dipyridamole ( 200 mg ) bd versus acetylsalicylic acid ( 75 mg dispersible tablet daily ) effect inhibition thromboxane B2 formation</brief_summary>
	<brief_title>Effects Acetylsalicylic Acid Compared With Combination Acetylsalicylic Acid + Modified-release Dipyridamole Serum Thromboxane B2 Formation Platelet Aggregation Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dipyridamole</mesh_term>
	<mesh_term>Aspirin , Dipyridamole Drug Combination</mesh_term>
	<criteria>Male female healthy volunteer age 20 50 year Clinically normal medical history Clinically normal finding physical examination Capable comprehend communicate effectively investigator staff provide informed consent Willing give inform consent prior participation trial ( i.e . prior trialspecific procedure ) Any clinically significant disease . ( A significant disease define disease opinion investigator may either put subject risk participation study disease may influence result study subject 's ability participate study ) Clinically significant abnormal baseline haematology , blood chemistry urinalysis finding Serum glutamateoxaloacetate transferase ( SGOT ) serum glutamatepyruvate transferase ( SGPT ) &gt; 80 IU/L , bilirubin &gt; 34 µmol/L creatinine &gt; 176 µmol/L regardless clinical condition . Repeat laboratory evaluation conduct subject Use dipyridamole , aspirin nonsteroidal antiinflammatory agent ( NSAID ) previous two week Active peptic ulceration history peptic ulcer disease Known history suspect hypersensitivity dipyridamole , aspirin , NSAID component test drug History bleed disorder History cerebral haemorrhage Resting , seat blood pressure le 90/60 mmHg Participation drug clinical trial within sixteen week prior start trial Any indication current previous abuse alcohol , solvent drug Any chronic illness Asthma Requirement medication one month study Pregnant nursing woman woman childbearing potential use medically approve mean contraception ( e.g . oral contraceptive , intrauterine device surgically sterile ) exclude Previous participation randomisation phase clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>